Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome

Gabrielle Page-Wilson; Pamela U. Freda; Thomas P. Jacobs; Alexander G. Khandji; Jeffrey N. Bruce; Sandra T. Foo; Kana Meece; Anne White; Sharon L. Wardlaw

doi:10.1210/jc.2014-1448

Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome

Gabrielle Page-Wilson, Pamela U. Freda, Thomas P. Jacobs, Alexander G. Khandji, Jeffrey N. Bruce, Sandra T. Foo, Kana Meece, Anne White, Sharon L. Wardlaw

Research output: Contribution to journal › Article › peer-review

Abstract

Copyright © 2014 by the Endocrine Society.Context: Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.Objective: The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.Design and Participants: Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.Results: Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vsCD [54.5 ±13.0 (SEM) vs 17.2 ± 1.5 fmol/mL; P

Original language	English
Pages (from-to)	E1838-E1845
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	99
Issue number	10
DOIs	https://doi.org/10.1210/jc.2014-1448
Publication status	Published - 1 Oct 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1210/jc.2014-1448

http://press.endocrine.org/doi/pdf/10.1210/jc.2014-1448

Cite this

@article{e84d88805ea54e74bd8537f7178c6ee9,

title = "Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome",

abstract = "Copyright {\textcopyright} 2014 by the Endocrine Society.Context: Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.Objective: The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.Design and Participants: Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.Results: Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vsCD [54.5 ±13.0 (SEM) vs 17.2 ± 1.5 fmol/mL; P",

author = "Gabrielle Page-Wilson and Freda, {Pamela U.} and Jacobs, {Thomas P.} and Khandji, {Alexander G.} and Bruce, {Jeffrey N.} and Foo, {Sandra T.} and Kana Meece and Anne White and Wardlaw, {Sharon L.}",

year = "2014",

month = oct,

day = "1",

doi = "10.1210/jc.2014-1448",

language = "English",

volume = "99",

pages = "E1838--E1845",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Endocrine Society",

number = "10",

}

TY - JOUR

T1 - Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome

AU - Page-Wilson, Gabrielle

AU - Freda, Pamela U.

AU - Jacobs, Thomas P.

AU - Khandji, Alexander G.

AU - Bruce, Jeffrey N.

AU - Foo, Sandra T.

AU - Meece, Kana

AU - White, Anne

AU - Wardlaw, Sharon L.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Copyright © 2014 by the Endocrine Society.Context: Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.Objective: The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.Design and Participants: Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.Results: Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vsCD [54.5 ±13.0 (SEM) vs 17.2 ± 1.5 fmol/mL; P

AB - Copyright © 2014 by the Endocrine Society.Context: Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.Objective: The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.Design and Participants: Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.Results: Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vsCD [54.5 ±13.0 (SEM) vs 17.2 ± 1.5 fmol/mL; P

U2 - 10.1210/jc.2014-1448

DO - 10.1210/jc.2014-1448

M3 - Article

VL - 99

SP - E1838-E1845

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -

Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this